JustinMoyersMD
Oncology • Los Angeles, CAHead & Neck Cancer, Melanoma, Sarcoma
Medical Oncology The Angeles Clinic and Research Institute A Cedars-Sinai Affiliate
Dr. Moyers is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
11800 Wilshire Blvd
Los Angeles, CA 90025Phone+1 310-231-2127- Is this information wrong?
Summary
- Justin T. Moyers is board certified medical oncologist at the Angeles Clinic & Research Institute.
His clinical interests include head and neck cancers, and skin cancers. He has research interests in developmental therapeutics and phase 1 clinical trials along with the use of biomarkers and genomic data for patient selection. He is currently on the editorial board for JCO Precision Oncology.
Dr. Moyers received a B.S. in Chemistry from the University of Kansas and subsequently completed medical school at the University of Kansas School of Medicine. He performed his residency in internal medicine residency at Providence St. Vincent Medical Center, in Portland, Oregon followed by a fellowship in Hematology and Oncology at Loma Linda University Medical Center in Loma Linda, CA. Finally, he completed a fellowship in the Department of Investigational Cancer Therapeutics (A Phase 1 Program) at the University of Texas MD Anderson Cancer Center in Houston, TX.
Education & Training
University of Texas M D Anderson Cancer CenterFellowship, Developmental Therapeutics In Oncology, 2020 - 2021
Loma Linda University Health Education ConsortiumFellowship, Hematology and Medical Oncology, 2017 - 2020
Providence Health & ServicesResidency, Internal Medicine, 2014 - 2017
University of Kansas School of MedicineClass of 2014, MD
University of KansasB.S., Chemistry, with Distinction, 2006 - 2010
Certifications & Licensure
CA State Medical License 2017 - 2025
TX State Medical License 2020 - 2021
OR State Medical License 2014 - 2017- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Abstract Merit Travel Grant European Society of Medical Oncology, 2022
- Scholar in Training Award American Association for Cancer Research, 2020
- Oral Presentation Award Oregon Chapter American College of Physicians, 2016
Clinical Trials
- A Study to Compare the Administration of Pembrolizumab After Surgery Versus Administration Both Before and After Surgery for High-Risk Melanoma Start of enrollment: 2019 Feb 15
- A Phase II/III Trial of Nivolumab, Ipilimumab, and GM-CSF in Patients With Advanced Melanoma Start of enrollment: 2015 Nov 23
- Testing the Addition of Navitoclax to the Combination of Dabrafenib and Trametinib in People Who Have BRAF Mutant Melanoma Start of enrollment: 2014 Mar 24
- Join now to see all
Publications & Presentations
PubMed
- 2 citationsImpact of Biomarker-Matched Therapies on Outcomes in Patients with Sarcoma Enrolled in Early-Phase Clinical Trials (SAMBA 101).Roberto Carmagnani Pestana, Justin T Moyers, Jason Roszik, Shiraj Sen, David S Hong, Aung Naing, Cynthia E Herzog, Siqing Fu, Sarina A Piha-Paul, Jordi Rodon, Timothy ...> ;Clinical Cancer Research. 2023 May 1
- 5 citationsGenomic Alterations and Tumor Mutation Burden in Merkel Cell Carcinoma.Danielle Brazel, Priyanka Kumar, Hung Doan, Tianyu Pan, Weining Shen, Ling Gao, Justin T Moyers> ;JAMA Network Open. 2023 Jan 3
- Correspondence on 'Outcomes of stage IV melanoma in the era of immunotherapy: a National Cancer Database (NCDB) analysis from 2014 to 2016' by Sussman et al.Christopher Grant, Garo Hagopian, Thuy B Tran, Gayathri Nagaraj, Justin T Moyers> ;Journal for Immunotherapy of Cancer. 2022 Dec 1
- Join now to see all
Abstracts/Posters
- Assessment of investigational new drugs (INDs) approved in USA and Europe after early phase trials using the ESMO-magnitude of clinical benefit scale (ESMO-MCBS)J.T. Moyers, D.J. Benjamin, D. Brazel, P. Kumar, V. Subbiah, European Society of Medical Oncology Congress 2022, Paris, France, 9/10/2022
- Precision oncology and tumor mutational burden (TMB) in Merkel cell carcinoma (MCC): An analysis of the AACR Project Genie real-world databaseJ.T. Moyers, D. Brazel, P. Kumar, European Society of Medical Oncology Congress 2022, Paris, France, 9/10/2022
- Immunotherapy in metastatic melanoma: A sociodemographic analysis of the National Cancer Database.Amie Patel, Justin Moyers, Gayathri Nagaraj, American Society of Clinical Oncology- Society of Immunotherapy in Cancer, Orlando, Florida, 2/4/2020
- Join now to see all
Press Mentions
Merck’s Keytruda Scores Triple Hit at AACRApril 19th, 2023- Personalized Cancer Vaccine May Work on Solid Tumors, and More from Part 2 of the AACR Virtual MeetingJune 23rd, 2020
- Real-World Data Back Immunotherapy in Stage III MelanomaJune 22nd, 2020
- Join now to see all
Professional Memberships
- Member
- International Association for the Study of Lung Cancer - IASLCMember
- Member
- European Society of Medical OncologyMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
